Printable Version

© 2017 Medical Travel Today

Medical Travel Today is a publication of CPR Strategic Marketing Communications, a public relations firm based near New York City that specializes in healthcare and life sciences, with an international clientele. CPR, its Partners, and clients are at the nexus of where medical travel is today, and where it will be tomorrow.

Laura Carabello

Managing Editor
Nathan Molinari

Assistant Managing Editor
Brittany Tedesco


From the Editor

From the Editor: This month in Medical Travel Today, Laura Carabello

News in Review

Life expectancy study shows many likely to live beyond 90 by 2030

Messi promotes Hepatitis C treatment in Egypt

Australia to subsidise heroin overdose reversal drug

Why Nigerians will continue to travel abroad for medical attention - Health Minister

Wait times are 'the defining feature' of health-care system

Spotlight Interview

Aaron Traywick, CEO, Ascendance Biomedical

Industry News

Part Three: ‘Choosing the Good Hospital'

MediWorld - China International Medical Travel Show launches in 2017 as China's premier health tourism event 

Health Outsourced Launches on Indiegogo

After the 2017 "...health in GREECE" Convention

Learn details of South Korea's medical tourism market

Government of Bermuda sues Lahey Clinic for bribery to obtain contracts

Upcoming Events

8th International Exhibition of Medical Treatment Abroad

Pan-African Health Tourism Congress

Medical Fair India 2017

Healthcare Travel Expo and International Medical Forum

Indonesia Health, Medical Treatment and Tourism Expo

Privacy Policy
By subscribing to Medical Travel Today and using the website medicaltraveltoday.com, you agree to the collection and use of your personal information as described in this policy. If we make any significant changes to this policy, we will notify you by posting a notice of such changes.

We care deeply about protecting your privacy. Please send any questions you may have to our editor.


We will never spam you or give your personal contact information to anyone without your expressed permission.
You can unsubscribe from the newsletter at any time.

How we treat your information

We will not spam our subscribers. You will receive Medical Travel Today only, and you can choose to unsubscribe at any time. Subscribers may opt in to receive occasional messages from our partners or sponsors

We will never disclose your personal information without your permission. We will never sell, rent or share your personal information with a 3rd party, especially your email addresses, without your express permission, unless:

You specifically request us to do so (e.g. you are having technical difficulties).
It is required by law.
It is necessary to maintain our system.

We will protect your information from other users. We may sell, rent or share information about user habits in aggregate only.

To unsubscribe, click here.


Volume 9, Issue 8

Dear Colleagues:

Many factors influence patients in their quest for medical care and prompt them to access cross-border care.  We all know that more affordable prices and enhanced care quality are driving these decisions, but are one-of-a kind treatment options still impacting the decision-making process?

This month, we learned that access to specialized treatment for a variety of terminal conditions, treatment that can't be provided in the U.S. or in a reasonable timeframe for the patient's needs, is of growing importance.  We discussed this issue, the emergence of breakthrough biomedical technology and treatments, and the future of the medical tourism industry with Aaron Traywick, CEO, Ascendance Biomedical (AB). In addition to providing support with all aspects of a patient's medical trip, including assistance with flights, accommodation and medical records, AB provides innovative options for patients. 

We're hearing about advanced technology and treatments that are emerging worldwide. South Korea's medical tourism market continues to expand as a result of many of these factors, along with the country's pioneering advances in plastic/cosmetic surgery and dentistry. 

Additionally, Egypt is emerging as a medical tourism destination for hepatitis C patients and Australia is to subsidize a drug that reverses heroin overdoses.

Read on to learn more.

We are going to begin featuring emerging partnerships between US Centers of Excellence and hospitals outside the US and would love to hear from US domestic and hospitals around the world that are either interested in pursuing relationships or exploring collaborative opportunities for knowledge transfer and patient referrals. Please be in touch! 

Laura Carabello
Executive Editor and Publisher
Medical Travel Today



Global Health Voyager

Follow us on Facebook and Twitter
For more information, visit http://www.medicaltraveltoday.com


Aaron Traywick, CEO, Ascendance Biomedical

Aaron Traywick

About Ascendance Biomedical
Ascendance Biomedical is a team of physicians, scientists and entrepreneurs unified in the mission to save and improve lives.

The company provides products and services which enable customers to access the most cutting-edge biomedical technologies and treatments in the world.

AB provides medical care and treatment, assistance with flights, accommodation, travel instructions, the processing of medical records, direct connection with medical personnel upon arrival, analysis of your case to get you the best price with local physicians and - most importantly - set you up to receive the required treatments and interventions for your condition.

About Aaron Traywick
Aaron Traywick serves as the CEO of Ascendance Biomedical (AB) and the managing director of AB's offshore clinical trials offerings. Aaron is a community organizer, public policy professional and human rights advocate. He has served in various public policy leadership and service capacities in positions ranging from local and state government to members of the United States Congress.

Medical Travel Today (MTT): Can you give our readers some background information about your company?

Aaron Traywick (AT): Our company works to increase access for patients in a variety of terminal and treatment conditions that can't be met here in the U.S. or in a reasonable timeframe for their needs.
We have a network of clinics, as well as research clinics in other countries to include patients for their enrollment and participation in experimental trials in which they can participate in the treatment and also help to generate scientific data necessary to advance the breakthrough of treatments here in the U.S.

MTT: How would you say this model supports the emergence of breakthrough treatments and technologies in healthcare?

AT: One primary example is the model we are currently using with our Inovium brand - our Inovium Ovarian Rejuvenation Trial.

We have partnered with researchers in Greece, San Diego, and the University of California-Berkeley, and we have pioneered the first PRP-based treatment for the reversal of menopause, one of the only known treatments for the reversal of menopause, and the restoration of healthy fertility levels in women.

For this model, we have designed rigorous scientific protocols following FDA best practices, and work to have clients within the fertility space refer them over to our clinics in Greece and San Diego.

Additionally, we have worked with the scientific community to have pre- and post-treatment, bloodwork and analysis done so that we can actually see the overall effect in women's health as a result of these trials.

This model is used with other companies that we work with in breakthrough treatments particularly in the field of mitigation of aging related disease for life extension.

We partner with many companies who have developed treatments and have experimental treatments on deck to address the underlying conditions that lead to terminal illnesses of aging.

MTT: You mentioned Greece but what other regions does your model serve?

AT: We serve globally and maintain relationships with three clinics around the world that are providing the Cimavax lung cancer vaccine currently available only in Cuba.

MTT: What fees are associated with this type of service?

AT: We have a very basic percentage that we request the patient provides if they can actually move forward with treatment.
Ascendance never asks anything of these patients if they are terminal, which many of them are. We work with those who can't afford the treatments once we process their medical records and receive approval, as well as our other clinics and non-profit agencies, to ensure that they can get some form of treatment for their condition.

When it comes to the clinical trials, each model requires different costs for delivery of the treatment according to our clinics. We also provide support for the patient and their insurance coverage to cover the cost of pre- and post-bloodwork and bloodwork analysis through our partner agencies.

About an 80 percent reinvestment of all our revenue goes directly into research and development for new treatment options and the provision of new facilities for delivery.

MTT: What is the latest research that you've conducted?

AT: The latest and most fascinating research thus far has been in the first senolytics treatment.

Senolytics can be regarded as the next generation of drugs like metformin, or rapamycin - which we've heard a lot about for being effective interventions for not just Type 2 diabetes and high blood pressure but for a variety of different aging related conditions - like multiple cancers, cognitive diseases, dementia, cardio-vascular diseases and heart diseases.

These drugs appear to be effective in the underlying causes and processes that lead to aging even in youth.

Senolytics take it one step further by reducing the overall senescent cells in the body, which are essentially junk cells that are highly associated with the proliferation of cancer and other age related conditions in the body.

Mayo Clinic did some research and discovered that the combination was able to decrease the senescent cell count by about 40 percent, as well as increase muscular endurance significantly with just one five-day treatment that lasted in terms of a positive effect up until six months later.

This was pretty landmark because most pharmaceutical treatments do not last that long typically after just one simple five-day use.

Our research was able to conduct those trials and confirm both the safety and the endurance in the short term, as well as increase the testosterone levels in the male subjects. The research is ongoing and fascinating.

It is even more fascinating to know that there really is this potential in humans as well.

MTT: How do you think preventative care can be more accessible in medical tourism?

AT: Preventative care hasn't been given a lot of support particularly in terms of federal funding in the U.S. and is the least funded out of all the practiced medicine that we know of.

There is significant demand for performance - an increase in maximizing performance in athletes and body builders, Silicon Valley types or what have you.

For us, this represents the same principle; it is prevention and it is also showing that you're not just preventing diseases, disease proliferation and aging by engaging medical tourism. You're also maximizing your performance, competitiveness and your fitness right here, right now.

By engaging medical tourism in this way, you are really investing in your future, as well as in the here and now and in what level of help would be required for you to continue to maintain peak performance.

MTT: What changes do you expect to see in the future of the medical tourism industry?

AT: If the Affordable Care Act is repealed, then I think we can continue to see many new competitive markets and competitive countries develop, providing much lower air travel, lodging and facilities to folks of all income classes here in the U.S. We will be able to take advantage of that, and medical tourism will grow exponentially. It is only a matter of time before the Chinese government plans execution to mass market medical tourism around the world in the same way that they have taken on the mass marketing of various treatments that have yet to be developed at affordable levels for citizens of all income.

Industry News

Part Three: 'Choosing the Good Hospital'
Helping medical tourists make informed decisions
by Sharon Kleefield

Parts One and Two were featured in January and February issues of MTT.

The influence of regulation of healthcare quality in the USA

Ernest Codman, a Boston surgeon in the 1930s, dedicated his medical career to the systematic and comprehensive study of 'end results' - the assessment of patient outcomes of surgery in American and later in Canadian hospitals - which eventually led to the standards and estab- lishment of what is now the Joint Commission. It was his work that established an initial system to track the outcomes of patient treatments and to identify the clinical problems as the foundation for improving the care of future patients. He believed that this information should be made public so that patients could be guided in their choice of physicians and hos- pitals. He recorded diagnostic and treatment errors and linked these errors to needed quality improvements (Millenson, 2000).

Codman established the American College of Surgeons (ACS), where his 'end result' approach was developed by the ACS as the Minimum Standard for Hospitals - a one-page set of requirements based on which the ACS began on-site inspections of hospitals. Codman's initiatives and the ACS led directly to the standardised assessment of outcomes of surgery in American and US hospitals. In 1950, the American College of Physicians, the American Hospital Association, the American Medical Association and the Canadian Medical Association joined with the ACS as corporate members to create the Joint Commission, an independent, not-for-profit organisation in Chicago, Illinois, whose primary purpose was to provide the standards for hospital quality (JCI, 2014).

In 1965 the US federal government required all hospitals to have Joint Commission accreditation in order to be approved for reimbursement for patient services. The Joint Commission was an outgrowth of the work of Ernest Codman, promoting hospital quality improvement based on outcomes management in patient care. The JCI was established in 1998 as a private, not-for-profit affiliate of the Joint Commission. Through voluntary international accreditation, the JCI extends its mission to help improve the quality of patient care internationally. The JCI accreditation is considered a 'seal of approval' for medical travellers and a marker for quality. A total of 815 healthcare organisations have JCI accreditation across 100 countries. Accreditation serves as evidence that a hospital can meet high standards for the structure and processes of managing care.

Hospital quality beyond accreditation

In 1980, Dr Avedis Donabedian defined quality of care as 'that kind of care which is expected to maximize an inclusive measure of patient welfare, after one has taken account of the bal- ance of expected gains and losses that attend the process of care in all its parts' (Donabedian, 2005). In 1984, the American Medical Association defined quality of care as that 'which consistently contributes to the improvement or maintenance of quality and/or duration of life' (Caper, 1988). One of the most widely cited definitions of quality was formulated by the Institute of Medicine in 1990 as the 'degree to which health services for patients increase the likelihood of desired health outcomes and are consistent with the current professional knowl- edge' (Kohn and Donaldson, 2000).

Healthcare professionals tend to define quality as the attributes and results of medical intervention - the technical definition of 'doing the right thing right'. This constitutes mak- ing the right professional/technical decisions about care for each patient and doing it with the right skill, judgement and timeliness of execution (Blumenthal, 1996). One important change beyond the more technical definition is the growing recognition that treatment should be responsive to the preferences and values of individual patients/consumers of healthcare services and that their opinions about care are important indicators for quality. 'Desired health outcomes' include the extent to which it meets the 'expectations' of patients (Kohn and Donaldson, 2000). Patients and consumers are more interested now in the quality and safety of care when choosing a hospital.

Evidence from the early 1991 Harvard Medical Practice Study was a landmark study of medical injury in the US (Brennan et al., 1991). The study was the first review of 30,121 ran- domly selected medical records from 51 randomly selected acute care hospitals in New York state. The results from this study were revealing: it showed that adverse events occurred in 4 per cent of hospitalisations, and 27.6 per cent of those adverse events were due to negligence. The study estimated that, among the 2,671,863 patients discharged from New York hospitals in 1984, there were 98,609 adverse events involving substandard management of patient care. Surgical wound infections accounted for nearly half of all surgical adverse events. Drug com- plications accounted for additional adverse events, including known and unknown allergies, wrong dosages, wrong drug or multiple drug interactions. This study revealed that most adverse events were preventable; however, errors in hospital care appeared much more common than was originally thought. The occurrence of such adverse events was a result of the interaction of the patient, the patient's disease and a complicated, highly technical system of medical care and patient management by physicians and other support personnel (Brennan et al., 1991; Leape, 1994; Leape et al., 1991).

To err is human

Following the Medical Practice Study, the Institute of Medicine, an advisory group to the US Department of Health and Human Services, published the report 'To Err is Human: Building a Safer Health Care System' (Kohn and Donaldson, 2000). This report precipitated major public health concerns because of the estimated 4 per cent of hospital deaths in the USA that resulted from preventable medical errors, including:

  • foreign objects retained after surgery (e.g. sponges, small instruments)
  • trauma and falls
  • collapsed lung due to a medical treatment
  • breathing failure after surgery
  • postoperative pulmonary embolism/deep-vein thrombosis (dangerous blood clot)
  • wound reopening post-surgery; wound infections
  • accidental cuts or tears linked to medical treatment.

The more common preventable errors included post-surgical infections due to poor cleanliness, HAIs due to poor hygiene practices and errors in drug management.

The publication of Making Health Care Safer II (Agency for Health Care Quality, 2012) pro- vides evidence-based patient safety practices that are strongly encouraged if hospitals are com- mitted to significant reductions in preventable harm to patients. These practices, if universally implemented, have been shown to reduce preventable errors, are measurable at the point of care and are closely linked to clinical outcomes (CDC, 2015; De Vrieset al., 2010; Haynes et al., 2009; Reames et al., 2015).

Since the Institute of Medicine report and the continued research by the USA and other countries, we have a pathway for providing an initial set of 'markers' for reducing errors and preventing harm in hospitals. Leaders in the medical tourism industry should apply the existing evidence for creating highly reliable hospital systems that minimise preventable harm for all patients and in particular for medical tourists. For those hospitals looking to become 'hubs' for medical tourism, the 'markers' shown in Table 19.1 are consistent with those identified in Making Health Care Safe II and provide an international strategy for promoting and competing for the best and cost-effective care. They are targeted at specific hospital practices that have been associated with reducing preventable harm and achieving good patient outcomes. Successful implementation and surveillance of these markers would encourage international hospitals to improve their organisational norms and standards of care.

Encouraging international hospitals to track these 'markers' and share these publicly will result in better-informed choices for medical tourists and facilitators and further the industry to better serve its diverse patient populations. Moving beyond choice of hospitals via the internet, social media and testimonials, the medical tourist deserves to understand and ask the questions regarding what to expect from care received. The Cleveland Clinic, with hospitals in the USA and abroad, is one of the best examples of an organisation that is committed to sharing quality data 'with the world'. Their goal is to make the principle of transparency a practical reality and a worldwide source for learning, both by the hospitals and by the patients they serve. Patients are encouraged to be part of these efforts by asking questions and sharing their concerns. Their Patient Safety Program reports on good hand hygiene practice, HAIs, completeness of medical record keeping, reducing risk of patient harm from falls and patient satisfaction (Cleveland Clinic, 2016).

A modest proposal for a deeply personal activity

A colleague taught me that practising medicine is the most intimate of professions. It remains so when practised anywhere in the world. The medical tourist, when choosing a hospital in a different country and different culture, depends on the expertise and established best practices of the hospital staff and physicians. As a global consumer of healthcare, medical tourists seek information, guidance and reassurance that their care will meet 'best practices' and they will not come by harm. As patients, they want to know that they will be treated with dignity, compas- sion and exemplary standards of care with good outcomes. In this chapter I identified landmark studies from the past two decades that inform the practice of medicine as to how to protect patients from preventable harm and risk. There continues to be substantial progress in awareness and efforts to employ established strategies for quality and safety improvement. The opportunity in the medical tourism industry lies in helping international hospitals adopt and benchmark best practices, thus reinforcing quality and safety for all medical tourists (Bergs et al., 2014; KPMG International Cooperative, 2011).

With no regulatory oversight of quality or common safety practices, medical tourists are only able to make partially informed decisions about choosing the right hospital for their treat- ment. A recent study identified a set of global measures of hospital quality. These hospital measures, extracted from administrative data of 6.5 million patient discharges, are aligned with these encouraged 'markers': blood incompatibility, patient falls, catheter-associated urinary tract infection, unexpected deaths of low-mortality diagnoses, HAIs, including surgical site infec- tions. The conclusion from this study was that these measures could be used to help determine whether hospitals are meeting a minimum level of safe care (Perla et al., 2015). The publication of Making Health Care Safer II (Shekelle et al., 2013) provides a list of similar safety practices and, if implemented, could significantly improve patient care internationally. These practices have been documented by earlier studies presented in this chapter, providing strong evidence for their effectiveness in reducing preventable harm at the point of care.

Adding to these safety practices, a medical outcomes study identified the importance of patient evaluations as an important 'marker' for quality, as these reflect the patient's own perceptions of care, in addition to clinical outcomes (Tarlov et al., 1989; Weldring and Smith, 2013). The relevance to medical tourism is the need to understand better and include the patients' perspective and assessment of their hospital care. Patient satisfaction surveys are an international tool for measuring patient experience and all hospitals should be encouraged to measure and report patient satisfaction. With basic statistical analysis these data would provide an additional 'generic' patient perspective along with the intervention-specific outcomes (Black, 2013).

The quality 'markers' presented in this chapter reflect the last decade of research that identified specific strategies for reducing preventable harm for hospitalised patients. The medical tour- ism industry, including those companies who arrange and refer patients to particular hospitals, must be 'strongly urged' to move this industry in the direction of maximising safety and quality of care internationally. The individual medical tourist must also be proactive and informed as to what questions to ask regarding a hospital's best practices of care as reflected by these 'markers'. This is a modest but important beginning to address the quality concerns of the industry and most of all to improve and protect patient safety internationally. Exercising the right to an 'informed consent' remains a basic ethical principle for all patients when seeking care. It is the responsibility of the medical tourism industry to understand and incorporate the evidence on preventing patient harm and to guide the medical tourist in choosing a hospital that can meet these modest but critical quality 'markers'. This commitment by the industry will help to improve global patient quality and safety and address the absence of information about compara- tive quality. Safety is an aspiration as well as a requirement to improve the quality of care for all patients. Patients believe in this aspiration as they give us their trust and accept risks and benefits in their pursuit of healthcare as medical tourists (Vincent and Amalberti, 2016).


Agency for Health Care Quality (2012) Inpatient Quality Indicators, Rockville, MD: US Department of Health and Human Services.

Allegranzi, B., Bagheri, N., Combescure, C., et al. (2011) 'Burden of endemic health-care-related infec- tion in developing countries: systematic review and meta-analysis.' The Lancet, 377, pp. 228-241.

Beauchamp, T. L. and Childress J. F. (2001) Principles of Biomedical Ethics, Oxford: Oxford University Press.

Bergs, J., Hellings, J., Cleemput, I., et al. (2014) 'Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications', British Journal of Surgery, 101 (3), pp. 150-158.

Black, N. (2013) 'Patient reported outcome measures could help transform health care', BMJ, p. 346.

Blumenthal, D. (1996) 'Quality of care - what is it?', The New England Journal of Medicine, 335, pp. 889-891.

Botterill, D., Pennings, G. and Mainil, T. (eds.) (2013) Medical Tourism and Transnational Health Care, New York, NY: Palgrave Macmillan, pp. 1-9.

Brennan, T. A., Leape, L. L., Laird, N., et al. (1991) 'Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I', The New England Journal of Medicine, 324, pp. 371-376.

Bumrungrad International Hospital, https://Brumrungrad.com (accessed 7th November 2015).

BusLine (2016) Time of India, www.thehindubusinessline.com, January 13.

Caper, P. (1988) 'The definition of quality,' Health Affairs, 7, pp. 49-61.

Centers for Disease Control and Prevention (CDC) (2015) National Healthcare Safety Network: Surgical Site Infection (SSI) Event, http://www.cdc.gov/homeandrecreationalsafety/ (accessed 23rd February 2016).

Cleveland Clinic (2016) Patient Safety Program, Quality and Patient Safety Institute, Cleveland, OH: Outcomes Books.

Cohen, I. G. (2015) Patients with Passports, Oxford: Oxford University Press, pp. 41-77.

Connell, J. (2013) 'Contemporary medical tourism: conceptualization, culture and commodification,' Tourism Management, 34, pp. 1-13.

Crooks, V. A. and Snyder, J. (2010) 'Regulating medical tourism.' Lancet, 376, pp. 1465-1467.

Crooks, V. A., Kingsbury, P., Snyder, J., et al. (2010) 'What is known about the patient's experience of medical tourism? A scoping review.' BMC Health Services Research, 10, p. 266.

De Vries, E. N., Prins, H. A., Crolla, R., et al. (2010) 'SURPASS Collaborative Group, Effect of a com- prehensive surgical safety system on patient outcomes', The New England Journal of Medicine, 363(20), pp. 1928-1937.

Donabedian, A. (1980) Explorations in Quality Assessment and Monitoring, Vol. 1, The Definition of Quality and Approaches to its Assessment, Ann Arbor, MI: Health Administration Press.

Donabedian, A. (2005) 'Evaluating the quality of medical care', Milbank Quarterly, 83(4), pp. 691-729.

EIU (2011) Traveling for Health, London: Economist Intelligence Unit.

Erdogan, S., Yilmaz, E. and Isletmecilgi, T. (2012) 'Medical tourism: an assessment on Turkey', Joint Conference of the 11th International Conference of Asia, Istanbul, Turkey.

Faden, R., Beauchamp, T. and King, N. M.P. (1986) A History and Theory of Informed Consent, New York:

Frost & Sullivan (2012) Rising Middle Income, Medical Tourism Create Impact for APAC Healthcare Market, http://www.frost.com/prod/servlet/press-release.pag?docid=254506089 (accessed 14th May 2016).

Greenfield, D. and Pawsey, M. (2014) 'Medical tourism raises questions that highlight the need for care and caution', Medical Journal of Australia, 201(10), pp. 568-569.

Haynes, A. B., Weiser, T. G., Berry, W. R., et al. (2009) 'Safe Surgery Saves Lives Study Group. A surgical safety checklist to reduce morbidity and mortality in a global population,' The New England Journal of Medicine, 360(5), pp. 491-499.

Hohm, C. and Snyder, J. (2015) 'It was the best decision of my life: a thematic content analysis of former medical tourists' patient testimonials', BMC Medical Ethics, 16, p. 8. International Living (2016) http://internationalliving.com/author/iladmin/ (accessed 9th July 2016).

Joint Commission International (2014) Accredited Health Care Organizations, www.jointcommissioninternational.org (accessed 24th February 2016).

Kohn, L. and Donaldson, M. (eds.) (2000) To Err is Human: Building a Safer Health Care System, Institute of Medicine, Washington, DC: National Academy Press.

KPMG International Cooperative (2011) 'Medical tourism gaining momentum', Issues Monitor, 7, pp. 1-13.

Labonte, R. (2013) 'Overview: medical tourism today: what, who, why and where? Travelling well: essays in medical tourism', in Transdisciplinary Studies in Population Health Series, Ottawa: Institute of Population Health: University of Ottawa, pp. 6-12. Leape, L. L. (1994) 'Error in medicine', JAMA, 272, p. 1851.

Leape, L. L., Brennan, T. A., Laird, N., et al. (1991) 'The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II', The New England Journal of Medicine, 1324, pp. 377-384.

Lunt, N. and Carrera, P. (2011) 'Systematic review of websites for prospective medical tourists', Tourism Review, 66, pp. 57-67.

Lunt, L. and Mannion, R. (2014) 'Patient mobility in the global marketplace: a multidisciplinary perspective', International Journal of Health Policy and Management, 2 (4), pp. 155-157.

Lunt, N., Hardey, M. and Mannion, R. (2010) 'Nip, tuck and click: medical tourism and the emergence of web-based health information', The Open Medical Informatics Journal, 4, pp. 1-11. 244

Lunt, N., Machin, L., Green, S., et al. (2011) 'Are there implications for quality of care for patients who participate in international medical tourism?' Expert Review of Pharmacoeconomics and Outcomes Research, 11(2), p. 133.

Mattoo, A. and Rathindran, R. (2006) 'How health insurance inhibits trade in health care', Health Affairs, 25(2), pp. 358-368.

Millenson, W. (2000) Ernest Amory Codman: The End Result of a Life in Medicine, Philadelphia: WB Saunders.

NaRonong, A. and NaRanong, V. (2011) 'The effect of medical tourism: Thailand's experience', Bulletin of the WHO, 89, pp. 336-344.

Ozan-Rafferty, M., Johnson, J., Shah, G., et al. (2014) 'In the words of the medical tourist: an analysis of internet narratives by health travelers to Turkey', Journal of Medical Internet Research, 16(2), p. 43.

Penney, K., Snyder, J., Crooks, V., et al. (2011) 'Risk communication and informed consent in the medical tourism industry: a thematic content analysis of Canadian broker websites', BMC Medical Ethics, 12, pp. 1-11.

Perla, R. J., Hohmann, S. F. and Annis, K. (2015) 'Whole-patient measure of safety: using administrative data to assess the probability of highly undesirable events during hospitalization', Journal of Healthcare Quarterly, 35(5), pp. 20-31.

Reames, B. N., Krell, R. W., Campbell, D. A., et al. (2015) 'A checklist-based intervention to improve surgical outcomes in Michigan: evaluation of the Keystone Surgery program', JAMA Surgery, 150(3), pp. 208-215.

Runnels, V. and Carrera, P. M. (2012) 'Why do patients engage in medical tourism?' Maturitas, 73, pp. 300-304.

Satyanarayana, K. H. (2008) 'Informed consent: an ethical obligation or legal compulsion?', Journal of Cutaneous and Aesthetic Surgery, 1(1), pp. 33-35.

Shekelle, P. G., Wachter, R. M., Pronovost, P. J., et al. (2013) 'Making health care safe II: an updated critical anlysis of the evidence for patient safety practices', Comparative Effectiveness Review, 211, AHRQ Publication no 13, Rockville, MD: Agency for Healthcare Research and Quality.

Snyder, J., Crooks, V. A., Kingsbury, P., et al. (2011) 'The patient's physician one-step removed: The evolving roles of medical tourism facilitators', Journal of Medical Ethics, 9, pp. 530-534.

Tarlov, A. R., Ware, J. E., Greenfield, S., et al. (1989) 'The Medical Outcomes Study, an application of methods for monitoring the results of medical care', JAMA, 262(7), pp. 925-930.

Turner, L. (2007) 'First world health care at third world prices: globalization, bioethics and medical tourism', BioSocieties, 2, pp. 303-325.

Turner, L. (2011) 'Quality in health care and globalization of health services: accreditation and regulatory oversight of medical tourism companies', International Journal of Quality in Healthcare, 23(1), pp. 1-7.

Turner, L. (2013a) 'Ethical dimensions of global healthcare', The Cambridge Quarterly of Healthcare Ethics, 22(2), pp. 170-180.

Turner, L. (2013b) 'Canadian medical travel companies and the globalization of health care', in Botterill, D., Pennings, G. and Mainil, T. (eds.) Medical Tourism and Transnational Health Care, New York: Palgrave Macmillan, pp. 151-178.

Vincent, C. and Amalberti, R. (2016) Progress and Challenges for Patient Safety, London: Springer Science and Business Media.

Weldring, T. and Smith, S. (2013) Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)', Health Services Insights, 6, pp. 61-68.

Woodman, J. (2014) Patients Beyond Borders, Chapel Hill: Healthy Travel Media.

Zimlichman, E., Henderson, D., Tamir, O., et al., (2013) 'Health care-associated infections, a meta-analysis of costs and financial impact on the US health care system', JAMA Internal Medicine, 173(22), pp. 2039-2046.

Industry News

MediWorld - China International Medical Travel Show launches in 2017 as China's premier health tourism event 

Uniquely addresses the world's greatest current surge in medical tourism; announces dates, venue

Shanghai, 7th February 2017: China's premier outbound medical tourism event, MediWorld - China International Medical Travel Show, today announced it will take place at the Portman Ritz-Carlton in Shanghai's exclusive Jing'an district, Friday 12th May to Sunday 14th May 2017. 

This timely exhibition and conference is expected to attract more than 5,000 affluent Chinese visitors with an interest in overseas travel for medical, wellness, fertility, anti-aging and beauty treatments, as well as 2,000 healthcare practitioners, hospital managers and medical tourism industry professionals from China and many other countries.

More than 50 of the world's leading international hospitals and clinics, second opinion providers, medical tourism facilitators, and online health and telemedicine platforms from the US, the UK, Europe and Asia-Pacific are expected to exhibit at MediWorld to meet prospective customers, start a dialogue with Chinese partners and gain their share of the huge Chinese healthcare market. 

The MediWorld theme, "Where China meets the world of medical tourism" captures the intent and essence of the event.

China is a rapidly growing outbound medical tourism market already worth over USD10 billion[1] and motivated by quality of care and travel experiences - not cost. A wave of medical travellers from China, with over 500,000 trips made in 2016[1], is being driven by major changes in demographics, epidemiology and an increasing ability to spend on medical care. (Source: [1] Global Growth Markets)

The MediWorld conference is an important aspect of the event, with a carefully thought-out program featuring world-class speakers from leading Chinese and international healthcare providers and other important stakeholders such as insurers, technology providers, investors and law firms. The two days of learning and networking will bring delegates up to speed on the latest strategies and opportunities in the industry - from both the business and clinical perspectives.

"High acuity Chinese patients seek treatment overseas to access new or experimental drugs and innovative technologies. I'm seeing a significant rise of the Chinese patient in healthcare destinations everywhere-from expensive elective procedures, to health check-ups and wellness treatments combined with an international business trip or a memorable travel experience," said Josef Woodman, CEO of Patients Beyond Borders and member of the MediWorld Board of Advisors.

Many high net worth Chinese patients look to locations such as the US, the UK, Germany, Turkey, Israel, Japan and Singapore for high quality health services and their reputation for medical excellence. Meanwhile, hundreds of thousands of affluent patients are heading to nearby Korea, Malaysia, Thailand and Taiwan for health check-ups and wellness treatments, in addition to cosmetic surgery, dental treatment and elective ophthalmology or orthopaedic procedures. The relaxation of China's one-child policy is also boosting travel for IVF, birth tourism and surrogacy, especially to Southeast Asia, the US and Canada.

For private hospitals and healthcare businesses with plans to expand into China, medical tourism is an ideal first step into the market and acts as a valuable pre-cursor to direct investment. It creates a natural channel for developing an understanding of Chinese private sector patients and building relationships with business partners, all while delivering a lucrative stand-alone revenue stream.

For more information, contact: 
China: Nicole Huang
+86 21 6217 0505 ext 111

UK: Pete Read
+44 773 986 5080

About MediWorld - China International Medical Travel Show
MediWorld is an unprecedented networking and learning event bringing together affluent Chinese health travellers, international hospitals and clinics, referring doctors, medical tourism facilitators, destination tourism organisations, online medical travel platforms, insurers and China's private hospitals. Further info: www.chinamediworld.com

About Comexposium

MediWorld is organised by the Comexposium Group, a top-five global event organiser involved in more than 170 B2C and B2B events across 11 different sectors, including healthcare, food, agriculture, fashion, security, digital, construction, high-tech, optics and transport. Comexposium hosts more than 3 million visitors and 45,000 exhibitors. Further info: www.compexposium.com

About Global Growth Markets

Global Growth Markets is Comexposium's strategic partner for MediWorld. GGM is an information, advisory and events firm helping healthcare, technology and industrial companies grow in international markets, with accurate and reliable intelligence from its consultants around the world. The company's clients benefit from local insights, clear strategic advice and partner matching. Further info: www.ggmkts.com


Industry News

Health Outsourced Launches on Indiegogo
A genius pairing of Affordable Healthcare and Travel

As of now, the Indiegogo campaign for the full service medical tourism agency Health Outsourced is up and running. The agency takes to the crowdfunding platform to give people interested in medical services, as well as possible backers an inside look at how this project came to be. For now, the project focuses on the United States and Canada, offering affordable healthcare solutions abroad for those who seek medical help and assistance, for free.

"We're confident that these efforts will bring people something they didn't even know was possible, but they definitely need: finding affordable health care. Our project will fit seamlessly into the medical tourism culture, enabling people to get what they need, when they need it, regardless of their financial situation," says Alexandr Repin, founder of Health Outsourced.

The goal of this campaign is to create a community of like-minded individuals looking to change the face of healthcare for the better. As Health Outsourced founder Alexandr Repin states himself, a crowdfunding campaign as a means of communication fits the project best.

"Crowdfunding is a relatively new, but fantastic way of gaining exposure, while observing people's genuine reactions, their wants. This helps us facilitate societal involvement, that will ultimately benefit the people involved. After all, it's people we want to help, so it's people we have to concentrate our efforts on," says Alexandr Repin.

Personal experiences have driven the founders of Health Outsourced to put their time and best interest into the project. They want to reach those who share the vision of creating sustainable healthcare solutions and ultimately offer people affordable alternatives to what is possible at the moment. The Health Outsourced website contains all the necessary information on hospitals, doctors and procedures, being of great value to prospective patients. Future plans include expanding to the UK and the EMEA region.

Health Outsourced is a startup based in Chisinau, Moldova. It's a full service medical tourism agency, offering people around the clock assistance in finding affordable medical care solutions abroad. The services are free of charge and are fully personalized to the patient's situation. As part of the Medical Tourism Association, Health Outsourced is directly connected to the hospitals involved in the program, offering patients all the necessary information on hospitals, doctors and procedures. Travel arrangements are part of the free services offered by Health Outsourced.

Media Contact: Alexandr Repin
Telephone Number: (415) 992-5092
Email: alex@healthoutsourced.com

Industry News

After the 2017 "...health in GREECE" Convention

Dear Health Tourism Stakeholders,

To keep you in the loop with what is happening on the Greek side.
Just finished with the 11 - 12 February 2017 "...health in GREECE" Convention - www.healthingreececonvention.gr (which, as president of the Greek Health Tourism Confederation, I co-staged together with Zita Congress - a prominent and much-respected conference organizer).

It was under the auspices of the Greek Ministry of Tourism, City of Athens and a number of other governmental organizations.

The event was honored by their participation, of the Secretary General, Ministry of Tourism, a Senior Officer of the Government Trade and Invest Organization (who spoke on the subject of investment in Health Tourism), the shadow Minister of Tourism (from the Government opposition), president of the Athens Medical Association, etc.

It was a purely Greek event - aimed at bringing together all Greek Health Tourism Sector Stakeholders, including the representatives of "competing" legal entities / industry representative bodies (IRBs).

The event had 3 hosted speakers from Turkey (see "speakers"), as part of an exploratory strategy to form alliances - even amongst "Competing Destinations".

For the good of the Sector, I made the point of of inviting and giving the opportunity to all sides to have a say (even though some of the "entities" are divisive and even systematically undermine our efforts).

Practically everything was in Greek - but I have attached, for your benefit (in English):

Constantine Constantinides, M.D., PhD.
(Director, healthCare cybernetics, Secretary General, Global Healthcare Travel Council, President, Greek Health Tourism Confederation) +30 6945857642

Industry News

Learn details of South Korea's medical tourism market
by Salil Modak
whatech.com- The report analyzes market data and provides a better understanding of medical tourists flow and revenue to South Korea.

South Korea Medical Tourism Market Insights, Opportunity, Analysis, Market Shares & Forecast 2017-2022 is a new market research publication announced by Reportstack. South Korea Medical Tourism Market is likely to reach nearly USD 2 Billion by the year end of 2022 growing at a CAGR of around 15% from 2017 to 2022.

Market growth can be attributed to factors such as technologically advanced treatments and medical procedures, pioneer in plastic/cosmetic surgery and dentistry, excellent medical practitioners & medical facilities, affordable medical costs and strong government support and initiatives.

Chinese medical tourists play a significant role in contributing revenue to the South Korea economy. China contributed more than 35% share in 2016.

China is likely to maintain dominance in South Korea Medical Tourism revenue share by the year end of 2022.

United States spot at second position in the revenue share with XX% share.

Other countries such as Japan, Russia, Kazakhstan and UAE emerge as the largest revenue generators in the South Korea Medical Tourism Market.

Report: South Korea Medical Tourism Market Insights, Opportunity, Analysis, Market Shares & Forecast 2017-2022.

The research report titled ""South Korea Medical Tourism Market Insights, Opportunity, Analysis, Market Shares & Forecast 2017 - 2022" provides detailed information on the South Korea Medical Tourism Market. This report analyzes market data and provides a better understanding of medical tourists flow and revenue to South Korea.

Market outlook in value terms for the forecasted period for South Korea Medical Tourism Market has been detailed in the report. Key industry news and medical procedures cost comparision are analyzed with details.

This report also entails a detailed description of growth drivers and inhibitors of the South Korea Medical Tourism Market.

Key Topics Covered in the Report

  • South Korea Medical Tourism Market Environment & Trend (2009 - 2022)
  • South Korea Medical Tourism Market Share & Forecast (2009 - 2022)
  • South Korea Medical Tourism Market - Countrywise Analysis
  • Medical Procedures - Cost Comparison Analysis
  • Industry News from South Korea Medical Tourism
  • Key Drivers and Inhibitors of the South Korea Medical Tourism Market

South Korea Medical Tourism Market - 12 Countries Covered

1) United States 
2) China
3) Japan
4) Russia
5) Mongolia
6) Vietnam
7) Philippines
8) Kazakhstan
9) Saudi Arabia
10) Uzbekistan
11) Indonesia
12) United Arab Emirates"

Industry News

Government of Bermuda sues Lahey Clinic for bribery to obtain contracts
by Ilene MacDonald

Fiercehealthcare.com- A prominent Massachusetts hospital has found itself at the center of a federal bribery lawsuit that alleges it bribed the former leader of Bermuda to steer health business to its clinic.

The racketing conspiracy between the Lahey Clinic and Dr. Ewart Brown, the former premier of Bermuda, spanned 20 years, according to the lawsuit obtained by the Boston Business Journal. It states that the healthcare provider gave Brown bribes disguised as consulting fees in exchange for Lahey receiving preferential treatment when it bid on healthcare contracts issued by the Bermudian government.

Furthermore, the suit alleges Lahey made millions of dollars reading and interpreting medically unnecessary MRI and CT scans at private health clinics in Bermuda that were owned by Brown.

To view the original article in its entirety, click here.

Industry News

Help Save a Life and Support MatchingDonors
100 percent of all donations on MatchingDonors.com go to help people get organ transplants on MatchingDonors.com.

MatchingDonors is a 501c3 nonprofit organization and the nation's largest online living organ donor organization finding living organ donors for people needing organ transplants. In conjunction with various health organizations throughout the United States we have created a very successful Public Service Announcement campaign to help people recognize that they can save lives by being a living organ donor, to encourage them to register as an altruistic living organ donor, and to make them realize they can help save the lives of people needing organ transplants by donating other things. This MatchingDonors Living Organ Donor Initiative program has already saved thousands of lives.



Upcoming Events

8th International Exhibition of Medical Treatment Abroad

March 14-16, 2017 - Expocentre Fairgrounds, Moscow, Russia
To learn more or to register click here.

Pan-African Health Tourism Congress

March 29-31, 2017 - Umfolozi Hotel Casino and Convention Resort, South Africa
To learn more or to register click here.

Medical Fair India 2017

April 6-8, 2017 - Pragati Maidan, New Delhi
To learn more or to register click here.

Healthcare Travel Expo and International Medical Forum

April 25-27, 2017 - Exhibition Center Kyiv Expo Plaza, Kiev City, Ukraine
To learn more or to register click here.

Indonesia Health, Medical Treatment and Tourism Expo

May 11-14th, 2017 - Jakarta Convention Center - Indonesia
To learn more or to register click here.

Find Us Online
https://staticapp.icpsc.com/icp/loadimage.php/mogile/1186122/035065021d95d7f9862a87fc23617226/image/png?token=f18cb10e0613bd9bb71bfc915c8d8275& Facebook
https://staticapp.icpsc.com/icp/loadimage.php/mogile/1186122/035065021d95d7f9862a87fc23617226/image/png?token=f18cb10e0613bd9bb71bfc915c8d8275& Twitter
https://staticapp.icpsc.com/icp/loadimage.php/mogile/1186122/035065021d95d7f9862a87fc23617226/image/png?token=f18cb10e0613bd9bb71bfc915c8d8275& LinkedIn

Medical Travel Today: Opinions and Perspectives on an Industry in the Making

Medical Travel Today - the authoritative newsletter for the worldwide medical travel industry - is pleased to announce publication of a new book, "Medical Travel Today: Opinions and Perspectives on an Industry in the Making."

Featuring 40 of the newsletter's most compelling interviews from the first five years of publication, the volume chronicles the explosive growth of international medical tourism as witnessed and experienced by some of the key stakeholders and players. A must-read for anyone interested or involved in the industry.

News in Review

Life expectancy study shows many likely to live beyond 90 by 2030
Reuters.com- According to a large international study, the average life expectancy will rise in many countries by 2030, with South Koreans likely to have the highest life expectancy and the United States one of the lowest among developed countries.

Messi promotes Hepatitis C treatment in Egypt
FreePressJournal.in- Argentinian football star Lionel Messi was in Egypt as the face of an initiative to promote the North African country as a medical tourism destination for hepatitis C patients.

Australia to subsidise heroin overdose reversal drug
Ianslive.in- The Victorian government in Australia on Friday said it will subsidise a drug that reverses heroin overdoses.

Why Nigerians will continue to travel abroad for medical attention - Health Minister
Nigeria's Dailypost.ng- Minister of Health, Prof. Issac Oyewole, has said Nigerians will continue to seek medical attention abroad, until the federal goverment is able to get $1billion annually.

Wait times are 'the defining feature' of health-care system
YorkRegion.com- Vern Catania was in agony with no relief in sight as he waited months for hip replacement surgery.


Do you know of any available job openings relative to the medical travel industry? We encourage readers to submit any available, relevant job opportunities along with its descriptions and requirements for fellow readers and industry professionals to consider. All submissions are appreciated.



Are you interested in spreading the word about your new business or platform? Have you considered a sponsored article? Medical Travel Today and U.S. Domestic Medical Travel are offering a brand-new marketing opportunity to help YOU increase your audience and generate exposure. Contact us at editor@medicaltraveltoday.com for additional details and pricing. We look forward to your participation!


Editor's Note: The information in Medical Travel Today is believed to be accurate, but in some instances, may represent opinion or judgment. The newsletter's providers do not guarantee the accuracy or completeness of any of the information and shall not be liable for any loss or damage caused - directly or indirectly - by or from the information. All information should be considered a supplement to - and not a substitute for - the care provided by a licensed healthcare provider or other appropriate expert. The appearance of advertising in this newsletter should in no way be interpreted as a product or service endorsement by the newsletter's providers.